Tuesday, 18 August 2026 · World
USD/EUR 0.8631 USD/GBP 0.7379 USD/JPY 159.3 USD/CNY 6.753 All rates →
RSS
EUROS The World Financial Report
Nº 38 Tuesday, 18 August 2026 · World Edition
LATEST
Deals & M&A

Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m

PE Hub · 1h ago
Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m

LEO Pharma, which the release describes as a global leader in medical dermatology, serves close to 100 million patients in more than 70 countries annually. The post Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m appeared first on PE Hub .

Read the full story at PE Hub →